Articles: 24.20 19 October 2013

Latest reviews from Cochrane

In this section we present an abstract of a review relevant to prescribing in general practice from the latest issue of The Cochrane Database of Systematic Reviews. To view the article in full or for further information, visit www.thecochranelibrary.com
Addition of leukotriene antagonists to inhaled corticosteroids …

More details...

Current approaches to the management of hepatitis C

Hepatitis C can lead to cirrhosis, decompensated liver disease and hepato – cellular carcinoma. The authors discuss today’s recommended management and the GP’s role in diagnosis, screening and referral.
Current approaches to the management of hepatitis C

More details...

Current recommended diagnosis and management of headache

Headache is a common presentation and patients need careful and detailed assessment and examination. Our Drug review focuses on key points and recent guidelines on the diagnosis and management of headache, followed by sources of further information and a review of the prescription data.
Current recommended …

More details...

ESC guidelines on managing AF

Management of atrial fibrillation (AF) has changed rapidly over the last decade making management of these potentially complex patients challenging. The European Society of Cardiology (ESC) has helped to distil appropriate strategies for AF management in their 2010 guidelines, updated in 2012.
ESC guidelines on managing …

More details...

Is the tide going out on fish oil supplements for CVD?

Angus Thompson weighs up the evidence for taking daily fish oil supplementation in the primary and secondary prevention of heart disease.
Is the tide going out on fish oil supplements for CVD

More details...

New from NICE

Most of the statements in this quality standard, developed to support NICE’s 2010 clinical guideline, concern initial and specialist assessment, nonpharmacological interventions (lifestyle change, containment products, urethral milking) and surgery. One sets a standard for medication review.
New from NICE

More details...

Oseltamivir marginally decreases flu duration; no decrease in flu complications

In this meta-analysis, patients with clinically diagnosed influenza treated with oseltamivir (Tamiflu) showed no reduction in complications and only 20 fewer hours of symptom duration than patients treated with placebo.
Oseltamivir marginally decreases flu duration no decrease in flu complications

More details...

Routine shingles vaccination in 70 and 79 year olds

Steve Chaplin and Dr Robert Johnson provide an overview of the properties of the shingles vaccine, which is now to be routinely offered to 70 and 79 year olds.
Routine shingles vaccination in 70 and 79 year olds

More details...

Zoely: new COC with a higher rate of amenorrhoea

Zoely is a new COC containing estradiol and nomegestrol, a novel progestogen. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Stephen Searle discusses its place in therapy.
Zoely new COC with a higher rate …

More details...

Web design and marketing agency Leamington Spa